HIGH EXPRESSION OF BCL-2 PREDICTS POOR OUTCOME IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS TREATED WITH CHOP-BASED CHEMOTHERAPY

被引：0
|
作者：
Lee, H. W. [1 ]
Choi, J. -H. [1 ]
Ahn, M. S. [1 ]
Kang, S. Y. [1 ]
Jeong, S. H. [1 ]
Park, J. S. [1 ]
Han, J. H. [2 ]
Kim, J. H. [2 ]
机构：
[1] Ajou Univ Hosp, Dept Hematol Oncol, Suwon, South Korea
[2] Ajou Univ Hosp, Dept Pathol, Suwon, South Korea
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [1] High expression of BcI-2 predicts poor outcome in diffuse large B-cell lymphoma (DLBCL) patients (pts) treated with CHOP-based chemotherapy
    Ahn, M.
    Choi, J.
    Kang, S.
    Han, J.
    Kim, J.
    Lee, H.
    Jeong, S.
    Park, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S851 - S852
  • [2] High expression of Bcl-2 to predict poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving CHOP-based chemotherapy.
    Lee, Hyun Woo
    Ahn, Mi Sun
    Han, Jae Ho
    Kang, Seok Yun
    Jeong, Seong Hyun
    Park, Jun Seong
    Kim, Jang Hee
    Choi, Jin-Hyuk
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [3] High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy
    Choi, Yong Won
    Ahn, Mi Sun
    Choi, Jin-Hyuk
    Lee, Hyun Woo
    Kang, Seok Yun
    Jeong, Seong Hyun
    Park, Joon Seong
    Han, Jae Ho
    Kim, Jang-Hee
    Sheen, Seung Soo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (02) : 210 - 218
  • [4] High expression of Bcl-2 predicts poor outcome in diffuse large B-cell lymphoma patients with low international prognostic index receiving R-CHOP chemotherapy
    Yong Won Choi
    Mi Sun Ahn
    Jin-Hyuk Choi
    Hyun Woo Lee
    Seok Yun Kang
    Seong Hyun Jeong
    Joon Seong Park
    Jae Ho Han
    Jang-Hee Kim
    Seung Soo Sheen
    International Journal of Hematology, 2016, 103 : 210 - 218
  • [5] PROGNOSTIC SIGNIFICANCE OF APOPTOSIS-RELATED PROTEINS IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS (PTS) TREATED WITH CHOP-BASED CHEMOTHERAPY
    Jeong, S. H.
    Lee, H. W.
    Ahn, M. S.
    Choi, J. H.
    Han, J. H.
    Park, J. S.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 632 - 632
  • [6] Mechanisms of bcl-2 protein expression in diffuse large B-cell lymphoma (DLBCL).
    Farinha, P
    Bebb, G
    Siebert, R
    Horsman, D
    Connors, JM
    Gascoyne, RD
    BLOOD, 2004, 104 (11) : 12A - 12A
  • [7] Identification of gene modules associated with survival of diffuse large B-cell lymphoma treated with CHOP-based chemotherapy
    YongChao Gao
    Bao Sun
    JingLei Hu
    Huan Ren
    HongHao Zhou
    Ling Chen
    Rong Liu
    Wei Zhang
    The Pharmacogenomics Journal, 2020, 20 : 705 - 716
  • [8] Identification of gene modules associated with survival of diffuse large B-cell lymphoma treated with CHOP-based chemotherapy
    Gao, YongChao
    Sun, Bao
    Hu, JingLei
    Ren, Huan
    Zhou, HongHao
    Chen, Ling
    Liu, Rong
    Zhang, Wei
    PHARMACOGENOMICS JOURNAL, 2020, 20 (05): : 705 - 716
  • [9] Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy
    Kiyoko Kawamura
    Akihiko Wada
    Ji-Yang Wang
    Quanhai Li
    Akihiro Ishii
    Hideki Tsujimura
    Toshiyuki Takagi
    Makiko Itami
    Yuji Tada
    Koichiro Tatsumi
    Hideaki Shimada
    Kenzo Hiroshima
    Masatoshi Tagawa
    Journal of Cancer Research and Clinical Oncology, 2016, 142 : 27 - 36
  • [10] Expression of activation-induced cytidine deaminase is associated with a poor prognosis of diffuse large B cell lymphoma patients treated with CHOP-based chemotherapy
    Kawamura, Kiyoko
    Wada, Akihiko
    Wang, Ji-Yang
    Li, Quanhai
    Ishii, Akihiro
    Tsujimura, Hideki
    Takagi, Toshiyuki
    Itami, Makiko
    Tada, Yuji
    Tatsumi, Koichiro
    Shimada, Hideaki
    Hiroshima, Kenzo
    Tagawa, Masatoshi
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2016, 142 (01) : 27 - 36
12345